Form D · Biotechnology
NIIKI PHARMA INC
Hoboken, NJ · CIK 0001420996
Offering snapshot reported Aug 10, 2011 · SEC filing
- Reported sold
- $1.69M Offering amount: $6M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$500,000 → $1,688,500
- Reported investors11 → 18
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2011 | Amendment | $1,688,500 | $1,188,500vs Mar 1, 2011 | 18 | SEC filing |
| Mar 1, 2011 | Initial | $500,000 | No comparison | 11 | SEC filing |
| Jul 23, 2010 | Amendment | $5,000,000 | $1,200,000vs Mar 11, 2010 | 25 | SEC filing |
| Mar 11, 2010 | Amendment | $3,800,000 | No comparison | 23 | SEC filing |
| Jan 21, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-156004
Source: Form D, filed Aug 10, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ali Ardakani | Director, Executive |
| Hooshmand Sheshbaradaran | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
80 River Street Suite 5 D
Hoboken, NJ, 07030
Hoboken, NJ, 07030